Portfolio company
Seranova Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops autoantibody-based therapeutics and discovery platforms for pharmaceutical partners and clinicians treating autoimmune diseases, cancer and neurodegenerative disorders.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Novogaia
This biotechnology company develops fungal-derived medicines and molecular structure decoding software for pharmaceutical researchers to treat autoimmune diseases.
Re-Aim Therapeutics
This early-stage biotechnology company develops antibody-based therapies that target and deplete disease-causing cells to treat patients with autoimmune and inflammatory disorders.
Ditto Biosciences
The company develops parasite-derived protein therapies for pharmaceutical and biotechnology partners to treat patients with autoimmune diseases using an artificial intelligence platform.
CircNova
This biotechnology company develops an artificial intelligence platform to design circular RNA therapeutics for biopharmaceutical partners to treat cancer and neurodegenerative diseases.
Serna Bio
This company develops an AI-native platform to discover small molecule drugs targeting RNA for pharmaceutical partners treating respiratory and other complex diseases.
AbCellera
This company develops antibody discovery technology and therapeutic medicines for biotechnology and pharmaceutical partners to treat cancer, autoimmune disorders and infectious diseases.
Nilo Therapeuti
This biotechnology company develops medicines that target neural circuits to treat patients with autoimmune and inflammatory diseases.
Rhapsogen
This biotechnology company develops precision biologic therapeutics to treat autoimmune diseases by modulating antibody effector functions for patients with inflammatory conditions.
